Search results
Showing 8101 to 8115 of 8905 results
Plus Sutures for preventing surgical site infection (MIB204)
This advice has been updated and replaced by NICE healthtech guidance guidance 586.
AnaConDa-S for sedation with volatile anaesthetics in intensive care (MIB229)
This advice has been updated and replaced by NICE healthtech guidance 607.
This advice has been updated and replaced by NICE Healthtech guidance 615.
KardiaMobile for the ambulatory detection of atrial fibrillation (MIB232)
This advice has been updated and replaced by NICE healthtech guidance 606.
This advice has been updated and replaced by NICE healthtech guidance 602.
Personal KinetiGraph for remote clinical management of Parkinson's disease (MIB258)
This advice has been updated and replaced by NICE healthtech guidance 657.
Faecal microbiota transplant for recurrent or refractory Clostridioides difficile infection (MIB247)
This advice has been updated and replaced by NICE guideline NG199.
PneuX for preventing ventilator-associated pneumonia in intensive care (MIB45)
This advice has been updated and replaced by NICE medical technologies guidance 48.
QbTest for the assessment of attention deficit hyperactivity disorder (ADHD) (MIB318)
This advice has been updated and replaced by NICE healthtech guidance 729.
BPMpathway for rehabilitation support in joint replacement surgery (MIB319)
MIB319 BPMpathway for rehabilitation support in joint replacement surgery has been withdrawn. This is because factual inaccuracies have been identified. NHS England no longer fund NICE to produce or maintain medtech innovation briefings, therefore these are no longer being reviewed.
Artificial intelligence for analysing chest X-ray images (MIB292)
This medtech innovation briefing has been updated and replaced by HealthTech guidance 696.
This medtech innovation briefing (MIB) has been replaced by NICE healthtech guidance 715.
This advice has been updated and replaced by NICE healthtech guidance 730.
Lenus COPD Support Service for remotely managing chronic obstructive pulmonary disease (MIB300)
This advice has been updated and replaced by NICE healthtech guidance 736.
Daylight for treating generalised anxiety disorder in adults (MIB309)
August 2023: This medtech innovation briefing (MIB) has been withdrawn at the company’s request as the evidence for the technology has moved on and the company expect to seek a NICE guidance output in due course.